Bank of America’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-758
| Closed | -$159 | – | 8075 |
|
|
2023
Q2 | $159 | Sell |
758
-44,378
| -98% | -$7.71K | ﹤0.01% | 7396 |
|
|
2023
Q1 | $7.22K | Buy |
45,136
+24,264
| +116% | +$10.8K | ﹤0.01% | 6992 |
|
|
2022
Q4 | $11.6K | Sell |
20,872
-61,278
| -75% | -$52.1K | ﹤0.01% | 6881 |
|
|
2022
Q3 | $98K | Sell |
82,150
-22,811
| -22% | -$24.6K | ﹤0.01% | 6359 |
|
|
2022
Q2 | $66K | Buy |
104,961
+99,709
| +1,898% | +$76.5K | ﹤0.01% | 6698 |
|
|
2022
Q1 | $6K | Sell |
5,252
-18,343
| -78% | -$21.9K | ﹤0.01% | 7873 |
|
|
2021
Q4 | $53K | Buy |
23,595
+15,117
| +178% | +$37.9K | ﹤0.01% | 7192 |
|
|
2021
Q3 | $29K | Sell |
8,478
-16,480
| -66% | -$50.8K | ﹤0.01% | 7281 |
|
|
2021
Q2 | $75K | Buy |
24,958
+7,336
| +42% | +$23.2K | ﹤0.01% | 6658 |
|
|
2021
Q1 | $57K | Buy |
17,622
+16,522
| +1,502% | +$55.1K | ﹤0.01% | 6596 |
|
|
2020
Q4 | $2K | Sell |
1,100
-1,216
| -53% | -$2K | ﹤0.01% | 6964 |
|
|
2020
Q3 | $2K | Buy |
2,316
+216
| +10% | +$222 | ﹤0.01% | 6724 |
|
|
2020
Q2 | $2K | Hold |
2,100
| – | – | ﹤0.01% | 6694 |
|
|
2020
Q1 | $2K | Sell |
2,100
-4
| -0.2% | -$5 | ﹤0.01% | 6668 |
|
|
2019
Q4 | $2K | Buy |
2,104
+166
| +9% | +$182 | ﹤0.01% | 6911 |
|
|
2019
Q3 | $2K | Buy |
1,938
+438
| +29% | +$597 | ﹤0.01% | 7025 |
|
|
2019
Q2 | $3K | Hold |
1,500
| – | – | ﹤0.01% | 6923 |
|
|
2019
Q1 | $3K | Hold |
1,500
| – | – | ﹤0.01% | 6868 |
|
|
2018
Q4 | $2K | Sell |
1,500
-651
| -30% | -$1.17K | ﹤0.01% | 6918 |
|
|
2018
Q3 | $6K | Buy |
2,151
+609
| +39% | +$1.26K | ﹤0.01% | 6797 |
|
|
2018
Q2 | $3K | Sell |
1,542
-1,661
| -52% | -$3.36K | ﹤0.01% | 6880 |
|
|
2018
Q1 | $7K | Sell |
3,203
-3,966
| -55% | -$8.5K | ﹤0.01% | 6710 |
|
|
2017
Q4 | $15K | Sell |
7,169
-3,590
| -33% | -$7.45K | ﹤0.01% | 6509 |
|
|
2017
Q3 | $14K | Sell |
10,759
-6,766
| -39% | -$8.4K | ﹤0.01% | 6433 |
|
|
2017
Q2 | $27K | Buy |
17,525
+8,478
| +94% | +$16.4K | ﹤0.01% | 6128 |
|
|
2017
Q1 | $29K | Sell |
9,047
-77,259
| -90% | -$190K | ﹤0.01% | 6165 |
|
|
2016
Q4 | $116K | Buy |
86,306
+4,876
| +6% | +$6.37K | ﹤0.01% | 5562 |
|
|
2016
Q3 | $127K | Buy |
81,430
+60,280
| +285% | +$92.6K | ﹤0.01% | 5340 |
|
|
2016
Q2 | $28K | Buy |
21,150
+16,072
| +317% | +$75.2K | ﹤0.01% | 6112 |
|
|
2016
Q1 | $26K | Sell |
5,078
-4,275
| -46% | -$26.2K | ﹤0.01% | 6042 |
|
|
2015
Q4 | $73K | Buy |
9,353
+5,998
| +179% | +$51.6K | ﹤0.01% | 5870 |
|
|
2015
Q3 | $28K | Sell |
3,355
-71,951
| -96% | -$664K | ﹤0.01% | 6205 |
|
|
2015
Q2 | $825K | Buy |
75,306
+50,395
| +202% | +$647K | ﹤0.01% | 4271 |
|
|
2015
Q1 | $348K | Sell |
24,911
-10,386
| -29% | -$159K | ﹤0.01% | 4564 |
|
|
2014
Q4 | $596K | Buy |
35,297
+27,340
| +344% | +$398K | ﹤0.01% | 4485 |
|
|
2014
Q3 | $107K | Sell |
7,957
-4,392
| -36% | -$52.3K | ﹤0.01% | 5955 |
|
|
2014
Q2 | $157K | Buy |
12,349
+10,100
| +449% | +$105K | ﹤0.01% | 5763 |
|
|
2014
Q1 | $27K | Sell |
2,249
-7,443
| -77% | -$99.9K | ﹤0.01% | 6762 |
|
|
2013
Q4 | $134K | Buy |
9,692
+2,978
| +44% | +$42.1K | ﹤0.01% | 5917 |
|
|
2013
Q3 | $117K | Sell |
6,714
-53,126
| -89% | -$1.02M | ﹤0.01% | 5849 |
|
|
2013
Q2 | $968K | Buy |
+59,840
| New | +$1.85M | ﹤0.01% | 4088 |
|
Other funds holding INFI
Bank of America's INFI Position: Q3 2023 in Review
Bank of America sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 758 shares — an estimated $159 sold.
Bank of America first reported a position in INFI in Q2 2013 and held it in 41 quarters. The position peaked at $968K in Q2 2013. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.
- Bank of America reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Bank of America sold 758 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $159.
- Bank of America first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 41 quarters.
- Bank of America's Infinity Pharmaceuticals, Inc. position peaked at $968K in Q2 2013.
- 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.
Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.